Souhaitez-vous accéder aux communiqués récents ?

Envetec approval creates new alternative to centralized medical waste treatment in Massachusetts.

Two of the world’s leading specialist healthcare investors with over $21 billion AUM are joining forces to create the largest dedicated healthcare investment manager globallyTogether, the group will...

Two of the world’s leading specialist healthcare investors with over $21 billion AUM are joining forces to create the largest dedicated healthcare investment manager globallyTogether, the group will...

PONTE VEDRA, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...

ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its...

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

Kneat announces record revenue for Q1 2026 of $18 million, up 18% from Q1 2025, and accelerating gross profit growth of 28% year-over-year.

DYADIC ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world...

- Phase 1 trial designed to evaluate the safety, tolerability, and pharmacokinetic properties of ICP-054 (ZB021) in healthy volunteers - Phase 1 SAD and MAD data expected by year-end 2026 BEIJING,...